Literature DB >> 17494791

Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy.

Virginia A Imadojemu1, Zubina Mawji, Allen Kunselman, Kristen S Gray, Cynthia S Hogeman, Urs A Leuenberger.   

Abstract

BACKGROUND: Sympathetic nerve activity is increased in awake and regularly breathing patients with obstructive sleep apnea (OSA). Over time, repetitive hypoxic stress could alter sympathetic chemoreflex function in OSA.
METHODS: We determined the responses to acute hypoxia (fraction of inspired oxygen of 0.1, for 5 min), static handgrip exercise, and the cold pressor test (CPT) in 24 patients with OSA (age, 50 +/- 3 years [mean +/- SEM]; apnea-hypopnea index, 47 +/- 6 events per hour) and in 14 age- and weight-matched nonapneic control subjects. Muscle sympathetic nerve activity (MSNA) [peroneal microneurography], BP, and ventilation were monitored.
RESULTS: Basal MSNA was higher in OSA patients compared to control subjects (45 +/- 4 bursts per minute vs 33 +/- 4 bursts per minute, respectively; p < 0.05). Furthermore, compared to control subjects, the MSNA responses to hypoxia were markedly enhanced in OSA (p < 0.001). Whereas the ventilatory responses to hypoxia tended to be increased in OSA (p = 0.06), the BP responses did not differ between the groups (p = 0.45). The neurocirculatory reflex responses to handgrip exercise and to the CPT were similar in the two groups (p = not significant). In OSA patients who were retested after 1 to 24 months of continuous positive airway pressure (CPAP) therapy (n = 11), basal MSNA (p < 0.01) and the responses of MSNA to hypoxia (p < 0.01) decreased significantly, whereas the ventilatory responses remained unchanged (p = 0.82).
CONCLUSION: These data suggest that the sympathetic responses to hypoxic chemoreflex stimulation are enhanced in OSA and may normalize in part following CPAP therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17494791     DOI: 10.1378/chest.06-2580

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  53 in total

Review 1.  Sympatho-adrenal activation by chronic intermittent hypoxia.

Authors:  Nanduri R Prabhakar; Ganesh K Kumar; Ying-Jie Peng
Journal:  J Appl Physiol (1985)       Date:  2012-06-21

Review 2.  Mediators of sympathetic activation in metabolic syndrome obesity.

Authors:  Nora E Straznicky; Nina Eikelis; Elisabeth A Lambert; Murray D Esler
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

3.  Brain stem activity changes associated with restored sympathetic drive following CPAP treatment in OSA subjects: a longitudinal investigation.

Authors:  Linda C Lundblad; Rania H Fatouleh; David K McKenzie; Vaughan G Macefield; Luke A Henderson
Journal:  J Neurophysiol       Date:  2015-05-20       Impact factor: 2.714

Review 4.  Apneic Sleep, Insufficient Sleep, and Hypertension.

Authors:  Meghna P Mansukhani; Naima Covassin; Virend K Somers
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

5.  Cerebral hemodynamic changes in obstructive sleep apnea syndrome after continuous positive airway pressure treatment.

Authors:  Pedro Enrique Jiménez Caballero; Ramón Coloma Navarro; Oscar Ayo Martín; Tomás Segura Martín
Journal:  Sleep Breath       Date:  2013-02-06       Impact factor: 2.816

6.  Effects of losartan and allopurinol on cardiorespiratory regulation in obstructive sleep apnoea.

Authors:  Barbara J Morgan; Mihaela Teodorescu; David F Pegelow; Emily R Jackson; Devin L Schneider; David T Plante; James P Gapinski; Scott J Hetzel; John M Dopp
Journal:  Exp Physiol       Date:  2018-06-08       Impact factor: 2.969

Review 7.  Upper airway function in the pathogenesis of obstructive sleep apnea: a review of the current literature.

Authors:  Robert L Owens; Danny J Eckert; Susie Yim Yeh; Atul Malhotra
Journal:  Curr Opin Pulm Med       Date:  2008-11       Impact factor: 3.155

Review 8.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

Review 9.  Sympathoadrenal mechanisms in the pathogenesis of sleep apnea-related hypertension.

Authors:  Oded Friedman; Alexander G Logan
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

Review 10.  Chemoreflexes, sleep apnea, and sympathetic dysregulation.

Authors:  Meghna P Mansukhani; Tomas Kara; Sean M Caples; Virend K Somers
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.